Dyadic receives grant from Gates Foundation for RSV antibody development

Dyadic receives grant from Gates Foundation for RSV antibody development

Submitted by admin on November 22, 2024 - 11:15am
Source: 
Pharmaceutical Business Review
News Tags: 
Dyadic
Gates Foundation
monoclonal antibodies
RSV
malaria
Headline: 
Dyadic receives grant from Gates Foundation for RSV antibody development
snippet: 

Dyadic International has received a $3m grant from the Bill & Melinda Gates Foundation to develop monoclonal antibodies (mAbs) for the treatment of respiratory syncytial virus (RSV) and malaria.

Do Not Allow Advertisers to Use My Personal information